Literature DB >> 21790110

Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain.

Andrew M Schimel1, Yale L Fisher, Harry W Flynn.   

Abstract

Optical coherence tomography (OCT) is an important imaging modality in the setting of diabetic macular edema (DME). Its use allows more precise evaluation of retinal pathology in DME, including retinal thickness and edema, vitreomacular interface abnormalities, subretinal fluid, and foveal microstructural changes. Additional advantages include its ability to quantitatively monitor response to treatment of DME by laser, intravitreal pharmacotherapies, and vitreoretinal surgery. OCT measurements are now used in all major clinical studies of DME treatment as critical endpoints. This article presents a review of both time-domain and spectral-domain OCT in the diagnosis and management of DME. The authors discuss the various parameters evaluated by the OCT systems and provide an evidence-based evaluation of their accuracy, significance, reliability, and limitations. As the capability of OCT continues to advance, it appears that its use will play an increasingly important role in the understanding, evaluation, and treatment of DME. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21790110     DOI: 10.3928/15428877-20110627-04

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  7 in total

Review 1.  Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.

Authors:  Gianni Virgili; Francesca Menchini; Giovanni Casazza; Ruth Hogg; Radha R Das; Xue Wang; Manuele Michelessi
Journal:  Cochrane Database Syst Rev       Date:  2015-01-07

2.  Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography.

Authors:  Xiao-Yong Chen; Wen-Jun Song; Hong-Yuan Cai; Lin Zhao
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

3.  Interobserver agreement in detecting spectral-domain optical coherence tomography features of diabetic macular edema.

Authors:  Ling Zhi Heng; Maria Pefkianaki; Maria Pefianaki; Philip Hykin; Praveen J Patel
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

4.  Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data.

Authors:  Srinivas R Sadda; Joanna Campbell; Pravin U Dugel; Nancy M Holekamp; Szilárd Kiss; Anat Loewenstein; Albert J Augustin; Vanessa Shih; Xiaoshu Xu; Charles C Wykoff; Scott M Whitcup
Journal:  Eye (Lond)       Date:  2019-07-18       Impact factor: 3.775

Review 5.  Spectral-domain optical coherence tomography for macular edema.

Authors:  Emmerson Badaró; Eduardo Novais; Larissa Maria Prodocimo; Juliana M Ferraz Sallum
Journal:  ScientificWorldJournal       Date:  2014-05-14

6.  Retinal diseases in a reference center from a Western Amazon capital city.

Authors:  Fernando Korn Malerbi; Nilson Hideo Matsudo; Adriano Biondi Monteiro Carneiro; Claudio Luiz Lottenberg
Journal:  Einstein (Sao Paulo)       Date:  2015 Oct-Dec

7.  ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data.

Authors:  Pravin U Dugel; Joanna H Campbell; Szilárd Kiss; Anat Loewenstein; Vanessa Shih; Xiaoshu Xu; Nancy M Holekamp; Albert J Augustin; Allen C Ho; Victor H Gonzalez; Scott M Whitcup
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.